CJC-1295 No DAC Mechanism of Action Explained

---

What is CJC-1295 No DAC?

The CJC-1295 No DAC mechanism of action describes how this synthetic growth hormone-releasing hormone (GHRH) analog interacts with the pituitary gland to stimulate growth hormone (GH) secretion.

Unlike the DAC version, the No DAC variant has a shorter half-life, making it more suitable for studying pulsatile hormone release patterns in research models.

---

🧬 CJC-1295 No DAC Mechanism of Action

CJC-1295 No DAC works by mimicking natural GHRH signaling.

Core biological actions:

• Activation of GHRH receptors in the pituitary gland
• Stimulation of growth hormone (GH) secretion pulses
• Support of IGF-1 downstream signaling
• Regulation of endocrine hormone rhythm patterns

---

🧠

$\text{CJC-1295 No DAC}\to \text{GHRH receptor activation}\to \text{GH pulse release}\to \text{IGF-1 signaling}$

---

Key Research Applications

CJC-1295 No DAC is studied in experimental models involving:

• Growth hormone pulse regulation
• Endocrine system signaling studies
• IGF-1 pathway research
• Hormone secretion rhythm modeling
• Metabolic and recovery-related research

---

Scientific Context

Research involving GHRH analogs like CJC-1295 is documented in PubMed and experimental registries such as ClinicalTrials.gov, focusing on growth hormone regulation and endocrine signaling pathways.

---

Regulatory Considerations (Europe)

Hormonal peptides are regulated by authorities including:

• European Medicines Agency
• Medicines and Healthcare products Regulatory Agency

Regulatory classification depends on jurisdiction and intended use.

---

Safety & Compliance Note

CJC-1295 No DAC is a biologically active research compound studied in controlled environments and should only be handled within appropriate research frameworks.